Treatment of vitiligo

Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete
M Meurer, M Schild

Abstract

The range of treatment options for vitiligo has significantly expanded in the last 10 years and we can offer our patients more effective treatment strategies supported by European guidelines and consensus findings. Topical and UV therapy are-often in combination-the main components of vitiligo treatment. The main outcome parameters include extent and maintenance of gained repigmentation, cessation of spreading, avoidance of side effects and the influence of the treatment on the quality of life. The efficacy of the currently available treatments is often limited. New options include antioxidative or melanocyte-stimulating adjuvant therapies in combination with UV or laser light as well as a topical maintenance treatment to reduce the risk of recurrences. In many cases, psychological support is indicated.

References

Feb 1, 1990·Journal of the American Academy of Dermatology·J R PorterJ J Nordlund
Jan 1, 1995·Dermatology : International Journal for Clinical and Investigative Dermatology·K U SchallreuterC Levenig
Jan 6, 1999·Archives of Dermatology·M D NjooP M Bossuyt
May 15, 1999·Dermatology : International Journal for Clinical and Investigative Dermatology·S Malakar, S Dhar
Oct 14, 2000·Journal of the European Academy of Dermatology and Venereology : JEADV·M Radmanesh
Jun 6, 2002·Journal of the European Academy of Dermatology and Venereology : JEADV·C ChiavériniJ P Ortonne
Oct 26, 2002·Dermatology : International Journal for Clinical and Investigative Dermatology·Michael MeurerUNKNOWN CASM-DE-01 study group
Oct 26, 2002·Dermatology : International Journal for Clinical and Investigative Dermatology·D A SmithJ M Hanifin
Jun 5, 2003·Clinical and Experimental Dermatology·D ParsadA Juneja
Jun 5, 2004·Dermatology : International Journal for Clinical and Investigative Dermatology·Michael MeurerUNKNOWN CASM-DE-01 Study Group
Jun 24, 2004·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Jaggi Rao, Richard E Fitzpatrick
Nov 25, 2004·Experimental Dermatology·Ching-Shuang WuHsin-Su Yu
Dec 20, 2005·The Journal of Investigative Dermatology. Symposium Proceedings·Nikolas K Haass, Meenhard Herlyn
Mar 1, 2006·Journal of the European Academy of Dermatology and Venereology : JEADV·M S KumaranB Kumar
Jul 21, 2006·The Journal of Dermatological Treatment·Mohammed Radmanesh, Kourosh Saedi
Nov 17, 2006·The Journal of Investigative Dermatology·Nicholas C J GibbonsKarin U Schallreuter
Jan 26, 2007·Pigment Cell Research·Alain TaïebUNKNOWN VETF Members
Feb 13, 2007·Trends in Cardiovascular Medicine·Ahlke Heydemann, Elizabeth M McNally
Jun 26, 2007·Dermatology : International Journal for Clinical and Investigative Dermatology·Dimitris RigopoulosDimitris Kalogeromitros
Sep 14, 2007·The Journal of Dermatological Treatment·Neslihan SendurEkin Savk
Oct 24, 2007·Clinical and Experimental Dermatology·M L Dell'AnnaM Picardo
Nov 19, 2008·The British Journal of Dermatology·R KapoorH R Jerajani
Jan 9, 2009·The New England Journal of Medicine·Alain Taïeb, Mauro Picardo
Jan 27, 2010·Indian Journal of Dermatology·Rafael Falabella
Apr 17, 2010·The Journal of Dermatological Treatment·Osman KöseZafer Kurumlu
Apr 23, 2010·The New England Journal of Medicine·Ying JinRichard A Spritz
Jun 16, 2010·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·K U Schallreuter, M M A E L Salem
Nov 9, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·K M AlGhamdi, A Kumar
Jun 7, 2011·The American Journal of Pathology·Sabita RanaGary Mark Halliday
Oct 7, 2011·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Magdalena Czarnecka-Operacz, Dorota Jenerowicz
Dec 27, 2011·Indian Journal of Dermatology, Venereology and Leprology·Iltefat H HamzaviZain U Syed
Dec 27, 2011·Indian Journal of Dermatology, Venereology and Leprology·Sushruta KathuriaVinod K Sharma
Jan 12, 2012·International Journal of Dermatology·Dong-Youn LeeDong-Youn Lee
Mar 1, 2012·Journal of the American Academy of Dermatology·Evelyn LillyRoopal V Kundu
Apr 25, 2012·The British Journal of Dermatology·K K ParkJ E Murase
Aug 7, 2012·The British Journal of Dermatology·A TaiebUNKNOWN Union Europe´enne des Me´decins Spe´cialistes (UEMS)
Dec 19, 2012·Dermatologic Therapy·Igor V Korobko

❮ Previous
Next ❯

Citations

Aug 23, 2016·International Wound Journal·Agata JanowskaMarco Romanelli
Oct 17, 2017·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·M Meurer, P Ceric-Dehdari

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Dermatology : International Journal for Clinical and Investigative Dermatology
D A SmithJ M Hanifin
Dermatology : International Journal for Clinical and Investigative Dermatology
Hassan SeirafiYahya Dowlati
Medizinische Monatsschrift für Pharmazeuten
Rudolf A Herbst
Vestnik dermatologii i venerologii
A Sh Mandel'
© 2022 Meta ULC. All rights reserved